Arsenic trioxide rewires mantle cell lymphoma response to bortezomib

Although most of the mantle cell lymphoma (MCL) patients initially responded well to bortezomib (BTZ), the dose-dependent toxicities have greatly limited the application of BTZ to MCL. To investigate the efficacy and mechanism of arsenic trioxide (ATO) with BTZ in inducing apoptosis of MCL cells, tw...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Zhao, Ling-Ling, Liu, Yuan-Fang, Peng, Li-Jun, Fei, Ai-Mei, Cui, Wen, Miao, Sheng-Chao, Hermine, Olivier, Gressin, Remy, Khochbin, Saadi, Chen, Sai-Juan, Wang, Jin, Mi, Jian-Qing
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2015
Assuntos:
Cancer Prevention
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4674002/
https://ncbi.nlm.nih.gov/pubmed/26310857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.511
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados